BioCentury
ARTICLE | Financial News

Onyvax raises L8 million

May 9, 2006 12:21 AM UTC

Cancer vaccine developer Onyvax (London, U.K.) raised L8 million ($14.2 million) in a series C round led by 3i Group and SR One. New investors Barrie Haigh and Alberville joined existing investors Mer...